DJIA 17,698.18 -77.94 -0.44%
NASDAQ 4,880.23 -20.66 -0.42%
S&P 500 2,059.69 -8.20 -0.40%
market minute promo

Gilead Sciences (NASDAQ: GILD)

97.72 -0.41 (-0.42%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $97.72 -0.42%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $98.16
Previous Close $98.13
Daily Range $95.38 - $98.16
52-Week Range $63.50 - $116.83
Market Cap $145.5B
P/E Ratio 13.35
Dividend (Yield) $0.00 (0.0%)
Volume 15,116,681
Average Daily Volume 10,107,782
Current FY EPS $9.89

Sector

Healthcare

Industry

Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary

Should Gilead Sciences, Inc. Be Worried By Achillion Pharmaceuticals?

Achillion Pharmaceuticals' ACH-3102 and ACH-3422 could eventually offer up an alternative to Gilead Sciences' HCV medicines.

Zacks Earnings Trends Highlights: Bank of America, Gilead Sciences and Apple - Press Releases

A Pre-Earnings Update On Gilead

5 Stocks to Buy for Big Revenue Growth

Gilead's Hep C Drug Receives Approval in Japan

Individual Investor Portfolio: Select Sectors And Companies Continue To Beat Market Indices And Peer

Individual Investor Portfolio: Select Sectors And Companies Continue To Beat Market Indices And Peer Groups

What to Look for This Earnings Season - Earnings Trends

What to Look for This Earnings Season - Earnings Outlook

Genfit Is An Even Bet To Recover In The NASH Race

Gilead Sciences Hovering Above Major Support Level

See More GILD News...

GILD's Top Competitors

GILD $97.72 (-0.42%)
Current stock: GILD
AMGN $157.10 (-1.72%)
Current stock: AMGN
CELG $114.57 (-0.62%)
Current stock: CELG
$0.00 (0.00%)
Current stock: